These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


471 related items for PubMed ID: 19142023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):2019-26. PubMed ID: 15542286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T, Morimoto S, Okaishi K, Kanda T, Nakahashi T, Okuro M, Murai H, Nishimura Y, Iwai K, Matsumoto M.
    Am J Hypertens; 2005 Oct 16; 18(10):1353-9. PubMed ID: 16202861
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N, Hashimoto N, Suzuki Y, Yagui K, Saito Y.
    Diabetes Res Clin Pract; 2006 May 16; 72(2):135-41. PubMed ID: 16290123
    [Abstract] [Full Text] [Related]

  • 13. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY, Sun M, Zhou HY, Pei ZF, Yang TL.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec 16; 29(6):686-9. PubMed ID: 16114558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L, Lei MX, Chen HL.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec 16; 28(6):553-6. PubMed ID: 15804059
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK, Luo JL, Tsai CT, Huang YT, Cheng CL, Lee JK, Lin LY, Lin JW, Hwang JJ, Chiang FT.
    Pharmacogenomics J; 2010 Feb 16; 10(1):46-53. PubMed ID: 19752885
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA, Pereira AC, Mota Gde F, Krieger JE, Mansur AJ.
    Arq Bras Cardiol; 2008 Apr 16; 90(4):252-6. PubMed ID: 18516385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH, Vagelos RH, Yee YG, Fowler MB.
    Am Heart J; 2004 Nov 16; 148(5):889-94. PubMed ID: 15523323
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.